US Stock MarketDetailed Quotes

TECX Tectonic Therapeutic

Watchlist
  • 45.460
  • +1.430+3.25%
Trading Nov 21 14:37 ET
670.66MMarket Cap-15462P/E (TTM)

Tectonic Therapeutic Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
94.16%19.64M
7.43%11.42M
10.11M
10.63M
110.31%32.83M
10.35M
15.61M
Selling and administrative expenses
168.69%5.32M
133.08%4.35M
--1.98M
--1.87M
54.89%7.18M
--2.07M
--4.63M
-General and administrative expense
168.69%5.32M
133.08%4.35M
--1.98M
--1.87M
54.89%7.18M
--2.07M
--4.63M
Research and development costs
76.01%14.32M
-19.30%7.07M
--8.13M
--8.77M
133.71%25.65M
--8.28M
--10.98M
Operating profit
-94.16%-19.64M
-7.43%-11.42M
-10.11M
-10.63M
-110.31%-32.83M
-10.35M
-15.61M
Net non-operating interest income expense
3,059.02%1.93M
57.61%290K
61K
184K
101.12%5K
53K
-445K
Non-operating interest income
1,912.37%1.95M
41.96%318K
--97K
--224K
--149K
--87K
--0
Non-operating interest expense
-30.56%25K
-30.00%28K
--36K
--40K
-67.64%144K
--34K
--445K
Other net income (expense)
-600.00%-7K
-19,150.00%-1.54M
-1K
-8K
-90.95%645K
0
7.13M
Gain on sale of security
----
----
----
----
-90.98%643K
--0
--7.13M
Other non- operating income (expenses)
-600.00%-7K
-19,150.00%-1.54M
---1K
---8K
0.00%2K
--0
--2K
Income before tax
-76.22%-17.72M
-21.20%-12.67M
-10.05M
-10.46M
-260.48%-32.18M
-10.29M
-8.93M
Income tax
Net income
-76.22%-17.72M
-21.20%-12.67M
-10.05M
-10.46M
-260.48%-32.18M
-10.29M
-8.93M
Net income continuous Operations
-76.22%-17.72M
-21.20%-12.67M
---10.05M
---10.46M
-260.48%-32.18M
---10.29M
---8.93M
Minority interest income
Net income attributable to the parent company
-76.22%-17.72M
-21.20%-12.67M
-10.05M
-10.46M
-260.48%-32.18M
-10.29M
-8.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-76.22%-17.72M
-21.20%-12.67M
-10.05M
-10.46M
-260.48%-32.18M
-10.29M
-8.93M
Basic earnings per share
-75.86%-1.2
-21.20%-0.86
-0.6824
-0.7096
-260.48%-2.184
-0.6985
-0.6059
Diluted earnings per share
-75.86%-1.2
-21.20%-0.86
-0.6824
-0.7096
-260.48%-2.184
-0.6985
-0.6059
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q3)Sep 30, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 0000000
Operating revenue --0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 94.16%19.64M7.43%11.42M10.11M10.63M110.31%32.83M10.35M15.61M
Selling and administrative expenses 168.69%5.32M133.08%4.35M--1.98M--1.87M54.89%7.18M--2.07M--4.63M
-General and administrative expense 168.69%5.32M133.08%4.35M--1.98M--1.87M54.89%7.18M--2.07M--4.63M
Research and development costs 76.01%14.32M-19.30%7.07M--8.13M--8.77M133.71%25.65M--8.28M--10.98M
Operating profit -94.16%-19.64M-7.43%-11.42M-10.11M-10.63M-110.31%-32.83M-10.35M-15.61M
Net non-operating interest income expense 3,059.02%1.93M57.61%290K61K184K101.12%5K53K-445K
Non-operating interest income 1,912.37%1.95M41.96%318K--97K--224K--149K--87K--0
Non-operating interest expense -30.56%25K-30.00%28K--36K--40K-67.64%144K--34K--445K
Other net income (expense) -600.00%-7K-19,150.00%-1.54M-1K-8K-90.95%645K07.13M
Gain on sale of security -----------------90.98%643K--0--7.13M
Other non- operating income (expenses) -600.00%-7K-19,150.00%-1.54M---1K---8K0.00%2K--0--2K
Income before tax -76.22%-17.72M-21.20%-12.67M-10.05M-10.46M-260.48%-32.18M-10.29M-8.93M
Income tax
Net income -76.22%-17.72M-21.20%-12.67M-10.05M-10.46M-260.48%-32.18M-10.29M-8.93M
Net income continuous Operations -76.22%-17.72M-21.20%-12.67M---10.05M---10.46M-260.48%-32.18M---10.29M---8.93M
Minority interest income
Net income attributable to the parent company -76.22%-17.72M-21.20%-12.67M-10.05M-10.46M-260.48%-32.18M-10.29M-8.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -76.22%-17.72M-21.20%-12.67M-10.05M-10.46M-260.48%-32.18M-10.29M-8.93M
Basic earnings per share -75.86%-1.2-21.20%-0.86-0.6824-0.7096-260.48%-2.184-0.6985-0.6059
Diluted earnings per share -75.86%-1.2-21.20%-0.86-0.6824-0.7096-260.48%-2.184-0.6985-0.6059
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data